Ironwood Pharma (IRWD)
3.75
-0.04 (1.06%)
Upcoming Events
Latest Headlines
Form 4 IRONWOOD PHARMACEUTICALS For: Jul 20 Filed by: Silber Jeffrey
July 22, 2026 4:10 PM - SEC Filing
Form 3 IRONWOOD PHARMACEUTICALS For: Jul 20 Filed by: Silber Jeffrey
July 22, 2026 4:05 PM - SEC Filing
Ironwood names new CMO as STARS-2 trial begins recruiting
July 14, 2026 7:30 AM - StreetInsider
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
July 14, 2026 7:30 AM - BizWire
Form 4 IRONWOOD PHARMACEUTICALS For: Jul 07 Filed by: Silver Ronald
July 9, 2026 4:33 PM - SEC Filing
Form 144 IRONWOOD PHARMACEUTICALS Filed by: Silver Ronald
July 7, 2026 4:44 PM - SEC Filing
Form 8-K IRONWOOD PHARMACEUTICALS For: Jun 16
June 18, 2026 4:15 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: Shepard Jay
June 17, 2026 4:47 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: Kessler Marla L
June 17, 2026 4:45 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: Currie Mark G
June 17, 2026 4:44 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: Duane Jon R
June 17, 2026 4:43 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 15 Filed by: DENNER ALEXANDER J
June 17, 2026 4:42 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: McHugh Julie
June 17, 2026 4:42 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: Jun 16 Filed by: Moukheibir Catherine
June 17, 2026 4:36 PM - SEC Filing
Form 144 IRONWOOD PHARMACEUTICALS Filed by: McHugh Julie
June 16, 2026 4:38 PM - SEC Filing
Form 8-K IRONWOOD PHARMACEUTICALS For: Jun 15
June 15, 2026 4:06 PM - SEC Filing
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 28, 2026 4:05 PM - BizWire
FDA approves LINZESS for children ages 2-5 with functional constipation
May 27, 2026 10:00 AM - StreetInsider
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
May 27, 2026 10:00 AM - BizWire
Form 8-K/A IRONWOOD PHARMACEUTICALS For: May 08
May 21, 2026 4:06 PM - SEC Filing
Form 4 IRONWOOD PHARMACEUTICALS For: May 19 Filed by: Silver Ronald
May 21, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:25 AM - SEC Filing
Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: RENAISSANCE TECHNOLOGIES LLC
May 14, 2026 4:46 PM - SEC Filing
Form 8-K IRONWOOD PHARMACEUTICALS For: May 08
May 13, 2026 8:01 AM - SEC Filing
Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31
May 7, 2026 4:10 PM - SEC Filing
Ironwood Pharma (IRWD) Tops Q1 EPS by 5c, provides guidance
May 7, 2026 7:21 AM - StreetInsider
Form 8-K IRONWOOD PHARMACEUTICALS For: May 07
May 7, 2026 7:10 AM - SEC Filing
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
May 7, 2026 7:05 AM - BizWire
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
May 4, 2026 7:05 AM - BizWire
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call
April 30, 2026 4:05 PM - BizWire
Form ARS IRONWOOD PHARMACEUTICALS For: Dec 31
April 28, 2026 4:12 PM - SEC Filing
Form DEFA14A IRONWOOD PHARMACEUTICALS
April 28, 2026 4:10 PM - SEC Filing
Form DEF 14A IRONWOOD PHARMACEUTICALS For: Jun 16
April 28, 2026 4:07 PM - SEC Filing
Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: BANK OF AMERICA CORP /DE/
April 27, 2026 12:59 PM - SEC Filing
Full Article List
